LC16m8

BIOLOGICAL2 trials

Sponsors

Universidad Nacional de Colombia, International Vaccine Institute

Conditions

MonkeypoxMpoxMpox (Monkeypox)

Phase 3

Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia

Active, not recruitingNCT06223919

Universidad Nacional de ColombiaMonkeypox

Start: 2023-12-16End: 2025-12-31Target: 8686Updated: 2025-09-04

Unknown Phase

Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)

RecruitingNCT07093489

International Vaccine InstituteMpox, Mpox (Monkeypox)

Start: 2025-12-03End: 2027-12-31Target: 11990Updated: 2026-08-31